Anbex Awarded Bid from Hong Kong’s Department of Health
April 4, 2024
St. George-based Anbex has been awarded a bid from Hong Kong’s Department of Health for the supply of 187,040, 130mg IOSAT tablets. Anbex had previously won a similar-sized award from Hong Kong in 2021 on the supply of their potassium iodide tablets. Anbex is currently bidding on the supply of IOSAT tablets to Mexico, Argentina, Brazil, and Saudi Arabia. Anbex contracts with St. George-based Deseret Labs to manufacture the tablets.
For more information, visit anbex.com.
Recent News
- Myriad Genetics Highlights New Research Advancements and Oncology Innovations at 2025 ASCO Annual Meeting
- BD to Initiate Real-World Patient Data Registry for the Rotarex™ Atherectomy System in Treatment of Peripheral Artery Disease
- Lessons in Innovation: Clark Turner’s Impact on Medical Imaging
- Merit Medical Acquires Biolife Delaware
- Pathos AI Secures $365 Million in Series D Financing to Advance Oncology Drug Development Through AI
- BD Launches Landmark Cell Analyzer Featuring Breakthrough Spectral and Real-Time Cell Imaging Technologies
